Furthermore, as a core regulator of PANoptosis, ZBP1 represents a potential therapeutic target; small molecule inhibitors or pathway-specific modulators could be designed to suppress aberrant inflammatory cell death and immune cell recruitment in periodontitis. This evidence concerns the gene ZBP1 and periodontitis.